Skip to content

EyePoint, Inc. EYPT Change in Deferred Revenue

Change in Deferred Revenue at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$99.6M+463%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$64K-3.2%
HRO
HarrowHROW
-$639K-733%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0+100%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$50K+84.8%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$274.92M-222%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's change in deferred revenue?
EyePoint, Inc. (EYPT) reported change in deferred revenue of -$0 in Q1 2026.
How has EyePoint, Inc. 's change in deferred revenue changed year-over-year?
EyePoint, Inc. 's change in deferred revenue increased by 100.0% year-over-year, from -$23.52M to -$0.
What is the long-term trend for EyePoint, Inc. 's change in deferred revenue?
Over 4 years (2021 to 2025), EyePoint, Inc. 's change in deferred revenue has grown at a 160.6% compound annual growth rate (CAGR), from -$931K to -$42.96M.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.